Health Notes- Amazing progress in several cancer cures

Health Notes

Amazing progress in several cancer cures

We ran across two articles discussing amazing progress against the Emperor of Maladies that we thought you’d find interesting.  Going back in our own Health Notes archives we found a couple more to share.  We hope they offer hope to anyone facing this devastating diagnosis, but the most hopeful thought might be this… no matter how much stuff we show you, it’s barely scratching the surface on todays’ cancer progress.  If you’re facing a cancer diagnosis it’s not necessarily a death sentence anymore… there is hope.

First, the most recent articles…

First Patient Injected With Experimental Cancer-Killing Virus in New Clinical Trial, Peter Dockrill in ScienceAlert.com, May 2022

An experimental cancer-killing virus has been administered to a human patient for the first time, with hopes the testing will ultimately reveal evidence of a new means of successfully fighting cancer tumors in people’s bodies.  The drug candidate, called CF33-hNIS (aka Vaxinia), is what’s called an oncolytic virus, a genetically modified virus designed to selectively infect and kill cancer cells while sparing healthy ones…

With the right molecular signal, a cancer drug works in every patient, Matthew Herper in STAT, June 2022

Sascha Roth was in her late 30s and feeling great. Then she noticed some bleeding when she used the bathroom. She went to see a gastroenterologist, who diagnosed her with rectal cancer. Her doctor, she recalled, “was as shocked as I was.”  A friend who had had colon cancer insisted Roth see her surgeon at Memorial Sloan Kettering Cancer Center. That led to her becoming patient no. 1 in a study that is a striking example of the importance of efforts to test cancer drugs in earlier stages of disease.

As part of the study, Roth received the cancer drug Jemperli, made by GSK. The treatment made her cancer shrink until it was undetectable — what doctors call a complete response. It did the same for the 13 other participants in the clinical trial, all of whom, like Roth, had locally advanced rectal cancer. So far, all of them have been spared radiation, chemotherapy, and disfiguring surgery that often involves the removal of the rectum.

The results are unprecedented and well beyond what the doctors conducting the study expected.  “What’s really remarkable is this is the first time I know of in solid tumor oncology where we’ve had a 100% complete response, and we’ve completely omitted the normal standard of care,” said Luis Diaz…

And here’s a encouraging look into our Health Notes Archives

Health Notes- Oh, nothing much… just a cure for cancer.  (T-Cell Therapies)  Tom Dwyer Automotive Services, Jan 2020

Health Notes- A cure for breast cancer? Not QUITE yet… (Provoking an immune response against cancer)  Tom Dwyer Automotive Services, Nov 2019

 

 

 

This entry was posted in 2022 May-June, Health Notes, Newsletter Columns, Newsletters. Bookmark the permalink.